A detailed history of Concord Asset Management, Llc/Va transactions in Abbott Laboratories stock. As of the latest transaction made, Concord Asset Management, Llc/Va holds 15,188 shares of ABT stock, worth $1.77 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
15,188
Previous 13,298 14.21%
Holding current value
$1.77 Million
Previous $1.38 Billion 25.31%
% of portfolio
0.39%
Previous 0.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$100.07 - $118.13 $189,132 - $223,265
1,890 Added 14.21%
15,188 $1.73 Billion
Q2 2024

Nov 06, 2024

BUY
$100.73 - $112.44 $122,286 - $136,502
1,214 Added 10.05%
13,298 $1.38 Billion
Q1 2024

Nov 06, 2024

BUY
$109.52 - $120.96 $173,370 - $191,479
1,583 Added 15.07%
12,084 $1.37 Billion
Q4 2023

Nov 06, 2024

BUY
$90.19 - $110.4 $947,085 - $1.16 Million
10,501 New
10,501 $1.16 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Concord Asset Management, Llc/Va Portfolio

Follow Concord Asset Management, Llc/Va and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Asset Management, Llc/Va, based on Form 13F filings with the SEC.

News

Stay updated on Concord Asset Management, Llc/Va with notifications on news.